Cover Image
市場調查報告書

開發中國家的感染疾病:預防藥、診斷藥的進步

Infectious Diseases in the Developing World - Preventative and Diagnostic Advances

出版商 Technical Insights (Frost & Sullivan) 商品編碼 348551
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
開發中國家的感染疾病:預防藥、診斷藥的進步 Infectious Diseases in the Developing World - Preventative and Diagnostic Advances
出版日期: 2015年12月30日 內容資訊: 英文 90 Pages
簡介

對每個國家來說感染疾病對策都是重要的課題。世界衛生組織 (WHO)制定 國際保健規則 (International Health Regulation) ,以努力削減各種感染疾病越過國境擴大的風險。

本報告提供各種感染疾病的預防藥和診斷藥的開發與普及情形相關分析、全球各地 (特別的發展中國家) 的發病情形,及現有的診斷藥、治療藥的普及情形、藥物開發主要的促進&阻礙因素、藥物開發的資金籌措方案、今後的藥物開發機會、主要企業的知識產權 (IP) 環境的資訊彙整,為您概述為以下內容。

第1章 摘要整理

  • 分析過程、手法
  • 分析的要點

第2章 市場結構的詳細分析

第3章 技術評估

  • 結核
  • HIV (人免疫力缺乏病毒)
  • C型肝炎病毒 (HCV)
  • 伊波拉
  • 登革熱
  • 瘧疾
  • HPV (人類乳突病毒)

第4章 影響度的評估與分析

  • 市場促進&阻礙的影響度的製圖
  • 對市場的影響度:推動因素詳細內容
  • 對市場的影響度:阻礙因素詳細內容

第5章 革新 (技術創新) 的擴散

  • 技術的引進

第6章 資金籌措方案

  • 資金籌措方案

第7章 市場機會的評估

  • 夥伴關係的評估
  • 企業合併、收購 (M&A)

第8章 知識產權 (IP) 情勢

  • HIV (人類免疫缺陷病毒) 診斷藥
  • HPV (人類乳突病毒) 診斷藥
  • C型肝炎病毒 (HCV) 診斷藥
  • 伊波拉診斷藥
  • 結核診斷藥
  • 瘧疾診斷藥
  • 登革熱診斷藥
  • 流感診斷藥

第9章 主要專利及聯繫資訊

第10章 關於Frost&Sullivan

目錄
Product Code: D6BD-01-00-00-00

Impact and assessment of novel diagnostic techniques to detect key infectious diseases

Infectious diseases that are caused by major pathogenic microorganisms such as viruses and bacteria pose severe public health challenges for individual governments. The International Health Regulations set up by the World Health Organization aims to cut down the risk of transfer of such infections across borders and limit the spread of disease. The research study on infectious diseases covers a range of diseases such as HIV, Ebola, Tuberculosis, Dengue, HPV, Malaria and HCV, which plague the developing regions currently. Additionally, the aim of this research service is to understand the existing diagnostics in the detection of these diseases as well as the diagnostic and preventative advances from key innovators that focus on regions of Africa, Asia and Latin America severely affected by infectious diseases. Apart from mapping the drivers and challenges that hold key to success of the diagnostics market for infectious diseases, the research study also details the healthcare structure, access and technology adoption in these three regions. Finally, the last three sections present the funding scenario, opportunity evaluation and IP landscape of key participants in the study.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Research Process Methodology
  • 2. Research Methodology (continued)
  • 3. Key Findings

2. SNEAK PREVIEW

  • 1. Overview
  • 2. Human Immunodeficiency Virus (HIV)
  • 3. Hepatitis C Virus (HCV)
  • 4. Human Papillomavirus (HPV)
  • 5. Tuberculosis
  • 6. Ebola
  • 7. Malaria
  • 8. Dengue

3. TECHNOLOGY ASSESSMENT

  • 1. Tuberculosis
  • 2. Tuberculosis
  • 3. Tuberculosis
  • 4. Tuberculosis
  • 5. Tuberculosis
  • 6. HIV
  • 7. HIV
  • 8. HIV
  • 9. HCV
  • 10. HCV
  • 11. HCV
  • 12. Ebola
  • 13. Ebola
  • 14. Ebola
  • 15. Ebola
  • 16. Ebola
  • 17. Dengue
  • 18. Dengue
  • 19. Dengue
  • 20. Dengue
  • 21. Malaria
  • 22. Malaria
  • 23. Malaria
  • 24. HPV
  • 25. HPV
  • 26. HPV
  • 27. HPVPreventative advances

4. IMPACT ASSESSMENT AND ANALYSIS

  • 1. Impact Mapping of Drivers and Challenges
  • 2. Market Impact-Drivers Explained
  • 3. Market Impact-Challenges Explained

5. DIFFUSION OF INNOVATIONS

  • 1. Technology Adoption
  • 2. Technology Adoption
  • 3. Technology Adoption

6. FUNDING SCENARIO

  • 1. Funding scenario
  • 2. Funding scenario
  • 3. Funding scenario
  • 4. Funding scenario
  • 5. Funding scenario
  • 6. Funding scenario

7. OPPORTUNITY EVALUATION

  • 1. Assessment of Partnerships
  • 2. Assessment of Partnerships (continued)
  • 3. Assessment of Partnerships (continued)
  • 4. Assessment of Partnerships (continued)
  • 5. Mergers and Acquisitions
  • 6. Mergers & Acquisitions (..contd)

8. IP LANDSCAPE

  • 1. HIV Diagnosis
  • 2. HPV Diagnosis
  • 3. HCV Diagnosis
  • 4. Ebola Diagnosis
  • 5. Tuberculosis Diagnosis
  • 6. Malaria Diagnosis
  • 7. Dengue Diagnosis
  • 8. Influenza Diagnosis

9. KEY PATENTS AND CONTACTS

  • 1. Global Patents
  • 2. Global Patents
  • 3. Global Patents
  • 4. Key contacts
  • 5. Legal Disclaimer

10. THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top